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Abstract
Background: One of the main issues of molecular evolution is to divulge the principles in dictating the
evolutionary rate differences among various gene classes. Immunological genes have received considerable
attention in evolutionary biology as candidates for local adaptation and for studying functionally important
polymorphisms. The normal structure and function of immunological genes will be distorted when they
experience mutations leading to immunological dysfunctions.
Results: Here, we examined the fundamental differences between the genes which on mutation give rise to
autoimmune or other immune system related diseases and the immunological genes that do not cause any
disease phenotypes. Although the disease genes examined are analogous to non-disease genes in product,
expression, function, and pathway affiliation, a statistically significant decrease in evolutionary rate has been found
in autoimmune disease genes relative to all other immune related diseases and non-disease genes. Possible ways
of accumulation of mutation in the three steps of the central dogma (DNA-mRNA-Protein) have been studied to
trace the mutational effects predisposed to disease consequence and acquiring higher selection pressure. Principal
Component Analysis and Multivariate Regression Analysis have established the predominant role of single
nucleotide polymorphisms in guiding the evolutionary rate of immunological disease and non-disease genes
followed by m-RNA abundance, paralogs number, fraction of phosphorylation residue, alternatively spliced exon,
protein residue burial and protein disorder.
Conclusions: Our study provides an empirical insight into the etiology of autoimmune disease genes and other
immunological diseases. The immediate utility of our study is to help in disease gene identification and may also
help in medicinal improvement of immune related disease.
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Background
The knowledge gleaned from several in silico studies has
facilitated in understanding the variability of evolution-
ary patterns in gene classes that can illuminate their
inherent characteristics. In particular, studies on the
functional and evolutionary attributes of human
immune system have attained a major focus since it is
an orchestra of various defense mechanisms whereby
human body maintains functional and organizational
integrity against foreign encroachment. The evolutionary
history of insects, chicken and mammals indicates that
the majority of immune response genes are subjected to
positive selection than remainder of the genes [1-3].
Immune response genes are also found to exhibit rapid
gene turn over i.e. gene gain and loss [4]. Contextually,
it has been proposed that probability of disease predis-
position is higher in the genes with high rates of non
synonymous mutations [5]. Diseases caused by abnormal
or absences of immunologic mechanisms are thus very
much common. According to disease mechanism,
immune system linked disease genes are generally cate-
gorized into two broad classes (i) Immunodeficiency-
dysregulation of the immune system in eliminating
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inactivation predisposed to immunologic disorder such
as AIDS, DiGeorge syndrome, Chronic granulomatous
disease, Wiskott-Aldrich Syndrome, Hypersensitivity etc
[6]. (ii) Autoimmunity- mistakenly immune system
launches attacks on its own tissue by confusing itself as
a foreign invader, leading to autoimmune disorder e.g.
Graves disease, Rheumatoid arthritis, Multiple sclerosis,
Goodpasture’s syndrome etc [6]. Till date various ana-
lyses with autoimmune diseases have attempted to figure
out their novel characteristics and possible mechanisms
[7-10]. Recently, it has been hypothesized that some
evolutionarily conserved proteins, present in pathogenic,
commensal organisms and their hosts, provide the sti-
mulus that initiates autoimmune disease in susceptible
individuals [9]. A possible mechanism of autoantigen
formation was thought to be instigated by increased
non-canonical splicing that renders untolerized epitopes
on antigen [10]. Although disorders caused by dysregu-
lation of immune system have been studied in separate
disease class, unique features of that entire disease genes
class are still uncharacterized.
Recently, more extensive focus has been concentrated
to scrutinize the disease genes for their unique charac-
teristics that distinguish them from the remainder of the
genome [11-13]. The growing incidence of autoimmune
and several immunological diseases have prompted us
to delve into the genic or proteomic features which
induce the disease causing mutation on host defense
genes. Evaluating the properties of functional immuno-
logical genes, malfunctioned immunological genes and
autoimmune disease genes in the evolutionary frame-
work we postulate that the autoimmune disease genes
are under the strongest purifying selection among the
three classes. We exemplified the underlying reasons by
assessing the mutational effect at DNA-mRNA-protein
levels. The comprehensive cataloguing and characteriza-
tion of genes from evolutionary perspective may provide
the basis for determining how nucleotide substitution
impacts biological function and instigate common
human diseases. Identification of the various features
that are responsible to distinguish between several
immunological disease and non-disease genes may help
to identify the probable biochemical basis for the disease
incidence. Our work may be extended in future in the
form of refining the specialized features of functional
and disease causing immunological genes.
Results
Evolutionary Dynamics of Immune Related Disease and
Non-disease Genes
The available resources of immunological disease genes
facilitate us to investigate the evolutionary pressure act-
ing on the autoimmune disease genes (AD) and other
classes of disease genes resulting from malfunctioning
immunological genes (ID) with respect to the immuno-
logical genes (IG) without known association to disease.
Our result depicts a significant [P value = 7 × 10
-3 (AD
vs ID); 1 × 10
-3 ( I Dv sI G ) ;4 . 6×1 0
-2 (AD vs IG)] gra-
dual increase in the ratio of non-synonymous to synon-
ymous substitutions (ω) [AD (mean ω = 0.336); ID
(mean ω = 0.344); IG (mean ω = 0.446)]. Such evolu-
tionary dynamics of disease and non-disease genes
linked to immunological genes is a bit surprising
because disease genes intuitively experience more muta-
tional changes than non-disease genes, yet they are
unable to escape the evolutionary pressure. It is obvious
that mutation or variation will occur either in gene or
m-RNA or protein level or in all the three levels to con-
fer disease phenotypes. We intend to investigate in
which level the mutation persuade the persistence of
selection pressure.
Effects of Gene level variations
The first wave of information from the human genome
analysis has revealed that single nucleotide polymorphisms
(SNPs) is the major resource of genetic and phenotypic
variations in human. Scanning for the signatures of posi-
tive selection in human population suggests that SNPs in
protein coding regions show regional evidence of less
intense purifying selection [14,15]. Investigating the
impact of SNPs in the coding region of above gene classes
exemplified that accumulation of non-synonymous SNPs
is significantly higher (Z score = 2.37, confidence level =
95%) in case of the AD (78.36%) compared to the ID
(73.04%) genes. Moreover, IG genes are themselves less
prone to non-synonymous substitutions (69.05%) than
both classes of disease genes [AD Vs IG (Z score = 5.0125
confidence level = 95%); ID Vs IG (Z score = 2.011 confi-
dence level = 95%)]. This observation clearly depicts that
the most conserved group of genes is indeed the most sen-
sitive ones to variation.
Secondly, the shuffling of genes brought about by
genetic recombination is a major engine of genetic varia-
tion. Recombination rate (RR) has been found to have a
positive correlation with DNA diversity in many organ-
isms, both in animals [16-18] and in plants [19]. Thus,
accumulation of higher amount of SNPs was expected to
initiate the higher RR for AD compared to ID and IG and
the result was also in accordance to the expectation (aver-
age RR (cM/Mb) for AD = 0.051, ID = 0.035, IG = 0.0023;
each value is significant at least at P<0.05 level in Mann-
Whitney test). Though the mutagenic nature of recombi-
nation rate may reflect the possibility of higher non-synon-
ymous substitutions, the prevalence of Hill-Robertson
interference in the genomic regions with higher RR have
been proposed to increase the efficacy of purifying selec-
tion [20,21]. Moreover, a positive association has been
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explains the lower evolutionary rate in regions with higher
recombination frequencies [22]. Analyzing microarray
expression data we also observed that on average the AD
genes tend to be more highly expressed than the other
two classes of genes (average expression for AD = 238.266;
ID = 175.138; IG = 128.497; each value is significant at
least at P<0.05 level in Mann-Whitney test). In addition to
that, RR has long been thought to be one of the principal
forces behind the gene duplication frequency [23,24]. Cal-
culating the paralogs number in three groups of genes
emphasized that the AD genes acquired a large number of
duplicates compared to ID and IG genes (Average paralogs
per genes for AD = 10.006; ID = 8.61, IG = 6.32; each
value was significant at least at P<0.05 level in Mann-
Whitney test). Higher duplicability may enforce the slower
evolutionary rate on AD genes in contrast to other two
classes since duplicated genes encounter more purifying
s e l e c t i o nt h a ns i n g l e t o n se v e nt h o u g hs h o r t l ya f t e rt h e
duplication, they experience a considerable relaxation of
selection pressure [25]. From this it can be inferred that
the SNPs and recombination rate collectively incite recur-
rent gene duplication (Spearman’s r SNP, RR = 0.120, P =
1.0 × 10
-3; Spearman’s r RR, paralogs number = 0.060, P = 1.0
×1 0
-3) and elicit the selection pressure on disease genes.
With the advent of genome scanning technology it has
uncovered that the human genome becomes structurally
dynamic due to the presence of thousands of heritable
copy of mutation and are equally important as SNPs [26].
It was reported that reduced purifying selection has been
acting upon copy number variants (CNVs) region [27].
Looking for the association of CNVs with immunological
disease and non-disease genes we noticed that the non-
disease immunological genes are significantly (Z-value =
1.96 at 95% confidence level) more prone (53.98% of total
immunological genes) to suffer from CNVs compared to
other immunological disease genes (49.72% of total other
immunological disease genes) while the later group of
disease genes (44.5% of total autoimmune disease genes)
exhibit significantly (Z value = 1.99 at 95% confidence
level) lesser CNVs than other immunological disease
genes. These findings are also consistent with the notion
that the CNV genes prefer to encode large numbers of
secreted, olfactory, and immunity proteins rather than
the genes harboring Mendelian disease [28]. Although
the disease genes concerned in our study are inherited by
both Mendelian and non-Mendelian fashion, we did not
observe any opposite trend for accounting the non-Men-
delian disease genes.
Effects of Transcript level Variations
Over the past decade, it has been postulated that alter-
native splicing (AS) is a critical post transcriptional
event directing an enhancement of transcriptome and
proteome diversity, particularly in higher organisms
[29]. The frequent accumulation of non-synonymous
mutations in alternatively spliced regions [30] initiates a
faster rate of evolution in alternatively spliced exons
than the constitutively spliced ones as evidenced from a
comparison of orthologous human and mouse genes
[31]. Investigation on the involvement of the three
groups of genes in alternative splicing mechanism
revealed that most of the IG genes favor alternative spli-
cing to increase their proteomic diversity in contrast to
AD and ID genes (Table 1). Accordingly, the profuse
number of alternatively spliced exons are encompassed
in IG genes compared to ID and AD genes (average
alternatively spliced exons per gene in AD = 5.89, ID =
6.78, IG = 8.85; each value is significant at least at
P<0.05 level in Mann-Whitney test). Such nature of IG
is also biologically relevant since it was proposed that
AS is crucial for a functional immune system as it offers
the potency of high degree of diversity and the compe-
tence of individual cells to rapidly adapt and respond
towards the changing environmental conditions [32,33].
Since, alternative splicing can bolster organism com-
plexity by effectively increasing the proteome size, the
m-RNA abundance would be higher for the immunolo-
gical genes. However, we already noticed IG genes are
lowly expressed. Accounting EST data, the trend remain
exactly same i.e. the EST count/m-RNA abundance is
lower for the IG (27.02) compared to ID (35.11) and AD
(48.72) genes. Hence, we ask what drives the lower m-
RNA abundance of AS rich immunological genes. In the
recent year it has been clarified that up to one-third of
human AS events create a premature termination codon
(PTC) that would cause the resulting mRNA to be
degraded by nonsense-mediated mRNA decay (NMD)
[34,35] and it was also stated that a higher rate of
mRNA decay can be considered as an indicator of the
lower gene expressivity [36]. Analysis on the coupling of
N M Dt ot h eA Sl i n k e dg e n e ss h o w st h a tm o s to ft h e
alternatively spliced isoforms of IG undergo mRNA
d e c a yw h i l et h ec o u n ti sm u c hl o w e rf o rI Da n dA D
genes (Table 1).
Another implication of alternative splicing is to pro-
mote intrinsically disordered protein, thus enabling
functional and regulatory diversity in human proteome
[37,38]. Calculation of disorder residues in the three
classes of proteins shows that the percentage of unstruc-
tured protein regions in IG, ID and AD genes are
respectively 44.23%, 32.22% and 21.52% and the differ-
ence between each of the above values is significant at P
< 0.05 (in Mann-Whitney test). The aberrant increase of
disorderness in IG proteins again confirms the high flex-
ibility of antigen binding sites in immunoglobulin
to combat against an almost infinite diversity of phy-
siological or synthetic antigens is predominantly
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[39]. Association with a large number of disorder resi-
dues of IG is also be an imperative reason for their fas-
ter evolutionary rate than AD and ID genes since in
some protein families it has been demonstrated that the
disordered regions evolve at a significantly faster rate
than the ordered regions [40].
Role of SNPs on Transcript level Variations
In recent years there has been growing evidence for
extensive natural variations like SNPs to be the major
contributor of alternative splicing variation in humans
[41]. Numerous disease-causing mutations within the
consensus 5’ splice site create a cryptic splice site that
leads to defective mRNA and protein products [42,43].
In our study, we also noticed a greater association of 5’
splice site SNPs (ss SNP) with AD genes compared to
ID and IG (Table 1). This phenomenon indicates that
SNPs impede the disease genes (AD, ID) to take part in
alternative splicing by altering the splicing signals and
their lower involvement with alternative splicing than
IG genes may imposes much more evolutionary pressure
on disease genes.
Effects of Protein level Variations
All proteins are potentially subjected to Post-transla-
tional Modifications (PMs) to accomplish many impor-
tant roles in regulating the biological processes such as
regulation of gene expression, activation/deactivation of
enzymatic activity, protein stability or destruction, med-
iation of protein-protein interactions etc [44]. However,
in some cases, PMs may be detrimental to protein func-
tionality and may compromise the cellular functions in
which they reside [45]. Among many of the modifica-
tions, post-translational phosphorylation is one of the
most common protein modifications that occur in ani-
mal cells. Calculation of PMs sites revealed that the
fraction of potential phosphorylation residues i.e serine,
threonine, and cysteine to the total length of the protein
is significantly (Mann-Whitney’s P < 0.05 in each case)
higher in case of AD genes (0.097) compared to ID
(0.084) and IG (0.069) genes. This observation again
emphasized the previous hypothesis that the abnormal
frequency of PMs uncover cryptic epitopes or create
some novel epitopes that may be not tolerated during
T-cell selection and trigger the pathogenesis of autoim-
mune disorder [45]. Contextually, it has recently been
discovered that an additional purifying selection are
operated on the positions involved in phosphorylation
as compared to their unmodified counterparts in the
same protein [46]. Thus the higher enrichment of post-
translational phosphorylation site in AD genes may be
considered as a potential reason for their lower evolu-
tionary rate.
Furthermore, it is well established that buried residues
in a protein are important determinants of protein stabi-
lity while surface residues are involved in protein func-
tion [47]. Here we found that AD genes bury more
residue on average compared to ID and IG genes (Fig-
ure 1). Since buried residues evolve at a slower rate
[48], the higher level of residue burial in AD genes can
be accounted for their lower sequence divergence and as
well as a possible means of achieving greater stability.
Role of SNPs on Protein level Variations
Systematic approach to the analysis of SNPs indicated
that SNPs resulting in deleterious amino acid changes
predominantly affect the stability of the protein [49].
We then map the non-synonymous SNPs on protein
buried region and quantify the hydrophobic, hydrophilic,
amphipathic amino acid substitution frequency in each
group of genes. The average amino acid exchange fre-
quencies among hydrophobic, hydrophilic and amphi-
pathic amino acids among AD, ID, IG genes for buried
regions of proteins are diagrammatically represented in
Figure 2. We noticed transition from hydrophilic to
hydrophobic or amphipathic to hydrophobic residue is
more frequently substituted in the buried regions of AD
proteins compared to ID and IG proteins. Moreover, the
hydrophobicity of buried region in AD genes has found
to increase significantly after substitution with SNPs
than ID genes while no change of hydrophobicity has
Table 1 Propensity of three classes of genes involved in different Alternative Splicing associated processes and their Z
- values of pair wise comparisons
Propensity of genes (%) Propensity of genes (%) Propensity of genes (%)
AD ID IG AD ID IG AD ID IG
Alternative
Splicing
79.5 84.38 89.79 NMD-linked
mRNA decay
11.65 18.2 34 5’splice
Site
SNPs
23.77 14.58 8.73
Significant
Level
(at 95%
confidence
level)
Z = 2.6
(AD vs. ID)
Z = 3.9
(ID vs IG)
Z = 7.5
(IG vs. AD)
Z = 1.7
(AD vs. ID)
Z = 5.5
(ID vs. IG)
Z = 7.6
(IG vs. AD)
Z = 1.03
(AD vs. ID)
Z = 4.8
(ID vs. IG)
Z = 7.5
(IG vs. AD)
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SNPs in increasing the hydrophobicity in buried region
of AD proteins may be responsible for evolutionary con-
straint for maintaining protein stability.
Relative Contribution of the Factors in Determining
Evolutionary Rate Variation
Here, we noticed different probable factors in the three
levels (DNA-m-RNA-Protein) that can explain evolu-
tionary rate differences among AD, ID and IG genes. To
assess the contribution of each variable, we compute
Principal Component Analysis (PCA). The dominant
eigen vectors (taken as equal to or greater than 1) that
appear from this analysis can be interpreted as the most
important contributors directing protein evolution [50].
PCA with gene level variables (SNPs, CNVs, RR, duplic-
ability); m-RNA level variables (isoform number, alter-
natively spliced exon, m-RNA abundance, disorderness);
protein level variables (phosphorylation, protein residue
burial), which are the dominant factors, are represented
in table 2. Multiple Regression Analysis was then per-
formed to assess the contribution of each level variables
determined in PCA in a single regression model from
which we can identify the influence of all potential
Figure 1 Distributions of buried and exposed residues among AD, ID and IG proteins. Error bar represents 5% standard error of data.
Figure 2 Average amino acid exchange frequencies due to Single Nucleotide Polymorphisms (SNPs) among hydrophobic, amphipathic
and hydrophilic amino acids for AD (black), ID (red), IG (blue) proteins.
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step by step those predictors that contribute least to the
regression model. Regression analysis exhaustively con-
firmed that the SNPs (b= -3.725), is the most influential
predictor of the evolutionary rate followed by the m-
RNA abundance (b= -3.005), paralogs number (b=
-2.036), fraction of phosphorylation residue (b = -2.091),
alternatively spliced exon (b =1 . 9 6 0 ) ,p r o t e i nr e s i d u e
burial (b= -1.085) and protein disorder (b = 1.021).
Discussion
Recent years have witnessed rapid progress in elucidat-
ing the molecular causes of various diseases. Here we
analyzed the evolutionary disparity between the func-
tional and non-functional immune systems. We noticed
that autoimmune disease genes are more conserved
than other immunological disease genes and both sets
of genes evolved significantly at a slower rate than
immunological genes. Though the evolutionary rates dif-
ferences among the gene groups are statistically signifi-
cant, the difference of mean values between
autoimmune and immunological disease genes is small.
However, the differences of mean values among the
groups turned out to be prominent when we analyzed
non-synonymous and synonymous substitution rates
separately (dn for autoimmune disease genes = 0.0079;
immunological disease genes = 0.0091; immunological
genes = 0.0118; Mann-Whitney’sP=1×1 0
-3 in each
case and ds for autoimmune disease genes = 0.0232;
immunological disease genes = 0.0254; immunological
genes = 0.0291; Mann-Whitney’s P < 0.05 in each case).
Significant differences in synonymous substitutions rates
among the gene groups indicate the role of neutral sub-
stitutions in driving the evolutionary rate discrepancies
among them. Now, the slower evolving disease linked
immune genes raise a fundamental question why non
disease immune genes evolve at a higher rate compared
to disease related immune genes since it was previously
documented by several studies that non-disease genes
evolve at a slower rate than disease genes [51,52],
though some controversial reports [11] are also present.
To resolve this controversy, our previous study [12]
exemplified that, monogenic diseases inherited by Men-
delian fashion and polygenic disease genes inherited by
non-Mendelian fashion are evolutionarily faster than
housekeeping genes but monogenic disease genes show
slower evolutionary rate than tissue specific genes. It is
also noteworthy to mention that immune system genes
show tissue-specific expression pattern [53] and both of
our disease datasets mostly comprise monogenic disease
genes (autoimmune disease genes dataset: 69% mono-
genic disorder, 31% polygenic disorder; other immuno-
logical disease genes dataset:61% monogenic disorder;
39% polygenic disorder). Herein, the differences in single
nucleotide polymorphisms, copy number variations,
recombination rate, duplicability, alternative splicing,
disorderness, post-translational modification, and pro-
tein residue burial can explain the evolutionary disparity
among the three groups of genes.
The evolutionary conservation of disease related
immunological genes in spite of their higher association
with non-synonymous single nucleotide polymorphisms
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Figure 3 Differences in average hydrophobicity score between the three categories of genes before mutation (wild type) and after
mutation (mutant type) with SNPs. P-value shows the significant level.
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genes (Figure 4). Single nucleotide polymorphisms up-
regulate recombination rates which in turns increase the
gene expression as well as paralogs number in disease
genes. Duplication driven disease gene formation has
also supported by a series of evidence in an earlier lit-
erature [54]. Previously, it was underscored that duplica-
tion and alternative splicing could not be operated
simultaneously rather they hold a negative correlation
with each other [55]. Since the disease genes achieved
their proteome size through gene duplication, we
observed a lower involvement with alternative splicing.
Here also single nucleotide polymorphisms played a cri-
tical role in 5’ splice site and create a cryptic splice site
by altering the splicing signal. On the other hand the
immunological genes follow the path of alternative spli-
cing to enhance their diversity. However, the frequent
link with alternative splicing could not generate higher
m-RNA abundance of immunological genes due to
“Regulated Unproductive Splicing and Translation”
(RUST) mechanism [56] in which premature termina-
tion codon containing isoforms are targeted to non-
sense mediated decay to regulate the transcript level of
functional protein. Rather alternative splicing helps to
impose a greater flexibility to bind with an enormous
number of foreign particles without known structural
analogy through increasing protein disorderness in
immunological genes (Spearman’s r disorderness, alternatively
spliced exon= 0.134, P = 1 × 10
-3). Thus, we deciphered
that the basic difference in the involvement of proteome
expansion machinery put differential selective pressures
on malfunctioning immune genes and the functional
immune genes. Moreover, it is also observed in our
search that autoimmune disease and other immunologi-
cal disease genes are more prone to post-translational
phosphorylation which may regarded as a possible rea-
son for slower evolutionary rate. In protein structure
level, the higher residue burial is observed in two types
of disease genes compared to non-disease genes and the
propensity of single nucleotide polymorphisms to substi-
tute hydrophilic, amphipathic amino acid by hydropho-
bic amino acid in disease groups could be prompted as
a reason of lower sequence divergence in autoimmune
disease and other immunological disease genes than
immunological genes. Conferring structural stability to
the autoimmune disease genes also has a biological sig-
nificance since incidence of autoimmunity sharply
increases in the stable protein forms in the cell [57].
Conclusions
Assessing the results from multivariate regression analysis
we conclude that the relative dominance of individual fac-
tors modulating the differential substitution rate experi-
enced by autoimmune disease, other immunological
Table 2 Principal Component Analysis on Evolutionary Rate (ω) with (a) Gene Level Predictors, (b) Transcript Level
Predictors, (c) Protein Level Predictors.
a. Gene Level Predictors
Principal Component1 Principal Component2
Percent of the total variance
Correlation Coefficient (Spearman’s r) with ω
27.502
-0.061**
21.912
0.113**
Major Contributing Factor in PCA1
Paralogs Number
Recombination Rate
0.789
0.805
—
—
Major Contributing Factor in PCA2
Single Nucleotide Polymorphism
Copy Number Variation
—
—
0.995
0.713
a. Transcript Level Predictors
Percent of the total variance
Correlation Coefficient (Spearman’s r) with ω
39.071
-0.161**
Major Contributing Factor in PCA1
m-RNA abundance
Alternatively Spliced Exons
Disorderness
0.702
0
0.688
0.446
c.Protein Level Predictors
Percent of the total variance
Correlation Coefficient (Spearman’s r) with ω
69.095
-0.321***
Major Contributing Factor in PCA1
Fraction of Phosphorylation Residues
Proportion of Buried Residues
0.557
0.743
N.B.: * denotes P <1 0
-3; ** denotes P <1 0
-6; *** denotes P <1 0
-9.
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single nucleotide polymorphisms > m-RNA abundance >
paralogs number > phosphorylation residue > alternatively
spliced exon > protein residue burial> protein disorder. To
the best of our knowledge, this is the first extensive com-
parison of disease and non-disease related immunological
genes from evolutionary perspective. This finding also
shades light into the mutational spectrum acting on DNA-
mRNA-protein level of the three classes of genes. Our
study will surely enrich the knowledge of disease gene
identification and may also help in medicinal improve-
ment of autoimmune disease.
Methods
Immune Related Disease and Non-disease Genes
Identification
Immune related disease genes mainly consist with Auto-
immune disease, Immunoproliferative disease, Immunolo-
gic deficiency syndromes, hypersensitivity, Graft rejection,
Purpura, thrombocytopenia, and Glomerulonephritis.
There exists a clear demarcation between the basic disease
mechanism of autoimmune disease and rest of the
immune related disease genes. Thus immune related dis-
ease genes are broadly categorized into the two groups -
autoimmune disease genes and other immunological dis-
ease genes. These two types of genes inherited by Mende-
lian and non-Mendelian fashion were downloaded from
Biobase and Genetic Association Database [58] respec-
tively. Autoimmune disease genes include Rheumatoid
Arthritis, Diabetes Mellitus, Systemic Lupus Erythemato-
sus, Greves disease, Thyroiditis, Antiphospholipid Syn-
drom, Pemphigus, Polyendocrynopathis, Hemolytic
anemia, Multiple Sclerosis etc. Then we have checked the
functional description of the gene sets downloaded from
Biobase and Genetic Association database. The link
between the functional description and disease association
was manually verified and the genes whose functional
descriptions match with disease associations were consid-
ered in our study while the genes which are common in
both autoimmune disease and other immunological dis-
eases were excluded from our dataset. Since the main
objective of our study is to find out the evolutionary dis-
parity among the gene sets, we have chosen only those
genes for which the information is available for their
orthologs in Chimpanzee and their dn and ds values in
Ensembl. Finally we have constructed the dataset with a
total of 781 autoimmune disease genes and 679 other
immunological disease genes (Additional file 1, Table S1).
Immunological genes were obtained from ImmPort [59]
and filtered with similar criteria. Finally we have acquired
2470 non-disease immunological genes by excluding the
above disease genes list (Additional file 1, Table S1).
Orthologs and Paralogs Identification
The gene sequences, paralogs information, pair-wise
non-synonymous substitution rates (dn) and synon-
ymous substitution rates (ds) with Chimp (1:1) orthologs
corresponding to both types of immunological disease
genes as well as non-disease genes were retrieved from
Ensembl [60].
Gene Expression Profile
The gene expression profile data was extracted from
BioGPS dataset [61]. The signal intensities across 79
Figure 4 The schematic representation to illustrate synchronous effect of Single Nucleotide Polymorphisms on recombination rate,
hydrophobicity, paralogs number, alternative splicing. Bold arrows denote significant correlations, +ve for positive and -ve for negative
while the dotted arrow indicates non-significant (NS) relationship between variables.
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level for each gene represented by their corresponding
probe id. mRNA abundance of the genes in our dataset
was calculated using EST data obtained from DFCI
Gene Indices. Gene expression level was estimated by
calculating the number of occurrences of each gene
among EST sequences from 179 cDNA libraries
sampled with at least 10,000 ESTs [62]. Eliminating
pathogenic and cancerous libraries, 41 libraries were
kept and alignments were made between the coding
sequences of the gene groups with the EST dataset
using BLASTN program with a sequence matching cri-
terion of 60% identity and 80% overlaps. The overall
EST counts for each gene across 41 EST libraries repre-
sented their mRNA abundance.
Measurement of SNPs, CNVs, Recombination Rate
Non-synonymous SNPs and CNVs information were
downloaded from Polydoms [63] and Database of Geno-
mic Variants [64] respectively. Chromosome wise gene
recombination rates were downloaded from Hapmap
project [65]. The recombination rates of the progenitor
genes were calculated using the formula ∑ri /l, where ri
stands for recombination rate at a base position and l
for the genic length corresponding to that gene [66].
Alternative Splicing and SNPs Effect
Data for alternatively spliced isoforms and exons for the
genes in the dataset were downloaded from the Alterna-
tive Splicing Annotation Project [67]. Splice site SNPs
information were collected from ssSNP Target [68].
Data for alternatively splicedi s o f o r m st h a ta r ec o u p l e d
to mRNA degradation were fetched from AS-ALPS [69].
Prediction of Intrinsically Disorder Region, Hydrophobicity
and Post-translational Phosphorylation
Disorder predictions were carried out using the program
FoldIndex [70] implementing the prediction method of
Uversky et al. [71]. Post translational phosphorylation in
the disease and non-disease related immunological pro-
teins were measured from NetPhos (2.0) [72]. Hydro-
phobicity values of proteins were retrieved from
ProtParam [73]
Calculation of Buried and Exposed Residues in Protein
Residue-wise burial in proteins was computed by a stan-
dalone version of sequence-based prediction program
RVP-Net [74]. This program relies on a neural network
trained to estimate solvent accessibility of each residue
from sequence features and was trained over non-redun-
dant set of protein structures. Predicted relative solvent
accessible surface area was converted to a two burial
classes (buried/exposed) at 16% cutoff, which roughly
corresponds to the median of solvent accessibility
distribution in training proteins. The classification of
amino acids as hydrophobic, hydrophilic and amphi-
pathic were done according to ref [75].
Statistical Test
We performed Mann-Whitney U test for pair-wise com-
parisons since the values are not normally distributed in
our dataset. Multiple regression analysis, Principal com-
ponent analysis were performed for relative contribution
analysis of each factors to evolutionary rate. All the statis-
tical tests were carried out by the SPSS (13.0) package.
Additional material
Additional file 1: Supplementary Table S1. Genomic and proteomic
features of Autoimmune disease, Immunological disease gens and
Immunological genes.
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